MINA Breaking News – Vitamin C: 1,000% more effective than Big … – MINA

Linus Pauling’s legacy continues, much to the chagrin of the
pharmaceutical industry. In a shocking new discovery published in the
scientific journal, Oncotarget, researchers have detailed how a
single, inexpensive nutrient, Vitamin C, can completely halt the growth
of cancer in stem cells when used in concentrated amounts. The vitamin
is so amazing, it was found to be 1,000 percent more effective than one
clinical drug that is currently prescribed all too often to treat
cancer, and another that is pending U.S. FDA approval.


The study, conducted at the University of Salford
in Manchester looked at metabolism in cancerous cells. Researchers
compared 3 natural substances, including Vitamin C, against 3
experimental pharmaceutical drugs, (meaning that they have not yet been
approved by the Food and Drug Administration) and one drug that is
already in widespread use.

The researchers stated,


We have discovered that NAD(P)H auto-fluorescence and several
mitochondrial-based fluorescent probes can all be employed to enrich for
a population of cells with the characteristics of CSCs. In accordance
with these observations, we also demonstrate that 7 different inhibitors
of key energetic pathways can be used to effectively block CSC
propagation, including three natural products (silibinin, ascorbic acid
and CAPE). Future studies will be necessary to test their potential for
clinical benefit in cancer patients.”



In layman’s terms, the study found that silibinin (an extract of milk thistle seeds), Vitamin C, and CAPE
(caffeic acid phenethyl ester) were effective cancer treatments, but
detailed elsewhere in the report, it was found that Vitamin C was 10
times more potent than 2-DG, an experimental pharmaceutical drug, for
the targeting of cancerous stem cells.


Though the study is being touted as “the first real evidence”
that Vitamin C, otherwise known as ascorbic acid, can kill cancer stem
cells (CSCs) – the very same cells that fuel the growth of cancerous
tumors – way back in 2006, there were two more studies published by the “complementary and alternative medicine” (CAM) crowd as evidence that Linus Pauling was vindicated.


It stands to note that cancer stem-like cells are thought to be the root cause
of chemotherapy resistance, leading to treatment failure in patients
with advanced disease and the triggers of tumor recurrence and
metastasis (regrowth of cancer cells).


Whether those studies vindicated Pauling or not, this latest research
offers irrefutable evidence that he was on to something big.


If you aren’t familiar with Pauling’s work,
he was the only person ever to win two unshared Nobel prizes. He also
happened to propose, along with Dr. Ewan Cameron, that even “terminal”
cancer patients treated with 10,000 mg of Vitamin C, administered
through an IV, could survive three to four times longer than patients
who did not receive such treatment.


Of course, the industry was quick to try to poo-poo his achievements.
His study was called “poorly designed,” and though there is a Linus
Pauling Institute carrying on his work to this day, we still don’t
routinely prescribe Vitamin C treatments for cancer patients, though
there has been corroborating evidence that it highly effective appearing repeatedly since Pauling’s discovery in the 1970s.

With the latest results published in Oncotarget, about Vitamin
C’s efficacy to treat cancer, there can no longer be any question that
the chemotherapy industry has been making trillions from people’s
useless “fight” against cancer – a disease that has dozens of natural
cures – Vitamin C being just one of many.


What does Vitamin C have in common with milk thistle extract, cannabis, turmeric, and over 200 additional natural cancer cures? It can’t be patented. And yet we wonder why there is still a massive chemotherapy and cancer drug industry. 

Comments

Write a Reply or Comment:

Your email address will not be published.*